A high-throughput cell-based assay for inhibitors of ABCG2 activity.
about
Discovery and resupply of pharmacologically active plant-derived natural products: A reviewA novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapyA combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian deliveryScreening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interferenceKnocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretionNew inhibitors of ABCG2 identified by high-throughput screeningBotryllamides: natural product inhibitors of ABCG2Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.Synthesis and structure-activity relationship of botryllamides that block the ABCG2 multidrug transporterLamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP mediated drug resistance in cancer cells.Inhibition of ABCG2-mediated drug efflux by naphthopyrones from marine crinoids.Dissecting variability in responses to cancer chemotherapy through systems pharmacology.Lamellarins as inhibitors of P-glycoprotein-mediated multidrug resistance in a human colon cancer cell line.Kinase inhibitor scaffolds against neurodegenerative diseases from a Southern Australian ascidian, Didemnum sp.ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma.A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cells.WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells.Oligomycins as inhibitors of K-Ras plasma membrane localisation.Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.Targeted therapy for cancer stem cells: the patched pathway and ABC transporters.Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.Matching the power of high throughput screening to the chemical diversity of natural productsFlavonoids from eight tropical plant species that inhibit the multidrug resistance transporter ABCG2ABCG2: the key to chemoresistance in cancer stem cells?Do stem-like cells play a role in drug resistance of sarcomas?Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.An evidence-based systematic review of chlorophyll by the Natural Standard Research Collaboration.Nature and uses of fluorescent dyes for drug transporter studies.Natural products for human health: an historical overview of the drug discovery approaches.Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib.Aurones as modulators of ABCG2 and ABCB1: synthesis and structure-activity relationships.Amycolatopsins A-C: antimycobacterial glycosylated polyketide macrolides from the Australian soil Amycolatopsis sp. MST-108494.Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.ATP Binding Cassette Sub-family Member 2 (ABCG2) and Xenobiotic Exposure During Early Mouse Embryonic Stem Cell Differentiation.Multidrug-resistant transporter expression does not always result in drug resistanceThe Effects of Synthetically Modified Natural Compounds on ABC Transporters
P2860
Q22252341-47798692-AF93-4272-99F0-995CE8BCAFA5Q28475529-78737F6D-9CBB-4ABE-97B4-3CF9A9A5933EQ28476831-9C1C3C10-A5EF-44CB-8AA8-A4C8B59DF629Q28486133-A4E58BEB-D6E5-4638-99FC-BCF119505ECCQ28570070-A43AEE39-749E-4F3F-BC37-7F66BB5CAEE9Q33311099-6C170F37-3F87-4A04-AD8E-81F0929E7802Q33474489-BA8D11C2-8620-4AA4-A9DE-6594A9A28297Q33476723-DA7F3B48-6324-46D2-A7B3-81BC7631EF39Q33764532-0A559077-5C28-40D5-AF35-848C5027D533Q33963488-D2EC7F80-5200-4C72-A8CC-DF56D962309CQ34077112-21ED83C1-7174-48B7-B0C1-075787258508Q34139962-CEE66AFF-65C6-4777-966B-F9208958FB0DQ34219546-6B5763F6-E79D-40F7-A08A-2C7CF37DFF41Q34244752-F37BD088-1100-4E94-930C-EE0262CD6C71Q34704841-2A1DD10F-4BDD-42D2-95EE-5EBC7A9BE8C0Q34977187-B592B7F1-EFA2-4B22-AFD9-AFEC3C651FDEQ35051599-F800BBF9-520E-40ED-88E3-5389051A5880Q35840615-B19A0422-85B3-41C6-BF13-4C493FEABE72Q35915497-A35C651D-1761-4845-8FA6-E4876E7A539CQ36745386-8064D41B-8553-40F9-BD5B-C9EA030E0A91Q37076348-620ACA00-B073-4722-ADDF-E74D289F4333Q37240957-8BFCA226-0ED4-444B-B85A-774BB9048A36Q37246870-CDD14C84-1E40-4E1C-B5F6-79DB5D885C23Q37587219-01494C33-BEBF-4C9D-9284-FE189280D168Q37687392-FE3CC4C3-F913-4AD6-9F30-7F80B4BBE3D1Q37821305-C8DA23C5-E53F-4143-9CDA-A93182D10411Q38155666-68C66C43-6DB4-42C7-9317-0ED089FC3712Q38199542-B8507E9D-0748-458D-868B-982BCA2B1E83Q38518912-D0CB3D82-FC72-4293-A175-C97A1143EAA8Q38651171-70159B4C-A2B7-45F1-A2F8-77DC04FE6B7EQ38718947-52AD9194-4EB7-432E-BAED-9152A3686E52Q39596096-248B32EC-9562-4AE2-A4CB-4A1DB68198B6Q47725603-86A808D4-B08F-4817-8B67-EB93B4E9AB26Q49843204-F3D4527B-CC27-4B5B-9821-9C8D4B1663B2Q52721223-EBA91B90-99A4-41D3-8A6D-F67E84C7974BQ54104981-DD1BFEC2-BC45-44AD-B1BC-411A03FB39CFQ58757448-B8E06BFE-EA86-4FA1-B227-0468706BDCB6Q58791987-323C11F1-49DF-4D15-BA2D-751AE5B14BE4
P2860
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@ast
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@en
type
label
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@ast
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@en
prefLabel
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@ast
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@en
P2093
P2860
P356
P1476
A high-throughput cell-based assay for inhibitors of ABCG2 activity.
@en
P2093
Curtis J Henrich
Ekaterina I Goncharova
Heidi R Bokesch
James B McMahon
Jennifer A Wilson
Susan E Bates
P2860
P304
P356
10.1177/1087057105284576
P577
2006-02-20T00:00:00Z